Method of using 4-(2-(P-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra

Details Method of using 4-(2-(P-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra Method of using 4-(2-(P-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra

1991-10-04

1993-09-07

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

5142378, 424 10, A61K 3166, A61K 31535, A61K 4900

Patent

active

052429091

ABSTRACT:
The use of 4-[2-[p-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-propeny l]phenoxy]ethyl]-morpholine, simultaneously, separately or sequentially in combination with a synergistically effective amount of cyclophosphamide in cancer prophylaxis or therapy for mammary tumors in mammals is described.

REFERENCES:
patent: 4940707 (1990-07-01), Klaus et al.
Carter et al., Chemotherapy of Cancer, 2nd Ed. John Wiley & Sons, N.Y., N.Y., pp. 67-68 (1981).

Affiliated with

Also associated with

Rating

Method of using 4-(2-(P-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of using 4-(2-(P-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using 4-(2-(P-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-487901